Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jesus E. Juarez"'
Autor:
Jesus E. Juarez, MD, Tahmineh Romero, MS, Constantine A. Mantz, MD, Abigail Pepin, MD, Nima Aghdam, MD, Simeng Suy, PhD, Michael L. Steinberg, MD, Rebecca G. Levin-Epstein, MD, Nicholas G. Nickols, MD, PhD, Irving D. Kaplan, MD, Robert M. Meier, MD, Huong T. Pham, MD, Patrick W. Linson, MD, Robert L. Hong, MD, Mark K. Buyyounouski, MD, Hilary P. Bagshaw, MD, Donald B. Fuller, MD, Alan J. Katz, MD, Andrew Loblaw, MD, Sean P. Collins, MD, PhD, Amar U. Kishan, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100759- (2021)
Purpose: To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD). Methods and Materials: We queried a consortium database for patients with IBD receiving SBRT for prostate
Externí odkaz:
https://doaj.org/article/0cfef0a7088e43cd9b104465d13bc9c8
Autor:
Rebecca Levin-Epstein, George Qiao-Guan, Jesus E. Juarez, Zhouhuizi Shen, Michael L. Steinberg, Dan Ruan, Luca Valle, Nicholas G. Nickols, Patrick A. Kupelian, Christopher R. King, Minsong Cao, Amar U. Kishan
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: To assess the optimal planning target volume (PTV) margins for stereotactic body radiotherapy (SBRT) of prostate cancer based on inter- and intra-fractional prostate motion determined from daily image guidance.Methods and Materials: Two hund
Externí odkaz:
https://doaj.org/article/f8d48c1eb9b14865a89603da4521c433
Autor:
Michael L. Steinberg, Kathleen Nguyen, Vinayak Muralidhar, Neil R. Parikh, Vincent Lok, Ting Martin Ma, Ida Sonni, Andrei Gafita, Pan Thin, David Elashoff, Johannes Czernin, Ricky Savjani, Matthew Rettig, Jesus E. Juarez, Jie Deng, Tristan Grogan, David Shabsovich, Amar U. Kishan, Patrick A. Kupelian, David D. Yang, Jeremie Calais, Nicholas G. Nickols, Carissa Chu, Felix Y. Feng, Wesley R Armstrong, Robert E. Reiter
Publikováno v:
Eur Urol Oncol
European urology oncology, vol 5, iss 1
European urology oncology, vol 5, iss 1
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is an emerging imaging modality with greater sensitivity and specificity over conventional imaging for prostate cancer (PCa) staging. Using data fro
Autor:
Amar U, Kishan, Nicholas, Marco, Melanie-Birte, Schulz-Jaavall, Michael L, Steinberg, Phuoc T, Tran, Jesus E, Juarez, Audrey, Dang, Donatello, Telesca, Wolfgang A, Lilleby, Joanne B, Weidhaas
Publikováno v:
Radiother Oncol
BACKGROUND AND PURPOSE: The purpose of this study was to determine whether single nucleotide polymorphisms disrupting microRNA targets (mirSNPs) can serve as predictive biomarkers for toxicity after radiotherapy for prostate cancer and whether these
Autor:
Neil Parikh, Pablo Borrelli, Kerstin Johnsson, Nicholas G. Nickols, Johan Brynolfsson, Lida Jafari, Matthias Eiber, M. Rettig, Jesus E. Juarez, Aseem Anand
Publikováno v:
Journal of Nuclear Medicine. 63:233-239
Rationale: Standardized staging and quantitative reporting is necessary to demonstrate the association of 18F-DCFPyL PET/CT (PSMA) imaging with clinical outcome. This work introduces an automated platform to implement and extend the Prostate Cancer M
Autor:
Rebecca Levin-Epstein, Naomi Y. Jiang, Jay Patel, Sartajdeep Kahlon, Nicholas D. Prionas, Nicholas G. Zaorsky, Shrinivasa K. Upadhyaya, Leszek Miszczyk, Sean P. Collins, Nicholas G. Nickols, Minsong Cao, Felix Y. Feng, Osama Mohamad, Nima Aghdam, Ye Yuan, Donald B. Fuller, Nzhde Agazaryan, A.T. Dang, Paul C. Boutros, A.U. Kishan, Constantine Mantz, Brandon A. Mahal, Amar U. Kishan, Daniel E. Spratt, Mark K. Buyyounouski, Michael L. Steinberg, David Shabsovich, Patrick A. Kupelian, Simeng Suy, Hilary P. Bagshaw, Alan J. Katz, Xiaoyan Wang, Tommy Jiang, Jesus E. Juarez, A. Napieralska, Ankur D. Patel, Agnieszka Namysł-Kaletka
Publikováno v:
Radiother Oncol
Background and purposeThe optimal dose for prostate stereotactic body radiotherapy (SBRT) is still unknown. This study evaluated the dose-response relationships for prostate-specific antigen (PSA) decay and biochemical recurrence (BCR) among 4 SBRT d
Autor:
Matthew Rettig, Ting Martin Ma, Jesus E. Juarez, Amar U. Kishan, Daniel E. Spratt, Jay Patel, Daniela Markovic, David Elashoff, David Shabsovich, Tommy Jiang, Robert E. Reiter, Nicholas G. Zaorsky, Nicholas G. Nickols
Publikováno v:
Prostate cancer and prostatic diseases, vol 25, iss 1
Background While multiple randomized trials have evaluated the benefit of radiation therapy (RT) dose escalation and the use and prolongation of androgen deprivation therapy (ADT) in the treatment of prostate cancer, few studies have evaluated the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03060bb31b6a2593671d9a883bc24594
https://escholarship.org/uc/item/5w90x2x0
https://escholarship.org/uc/item/5w90x2x0
Autor:
Amar U. Kishan, Alison Steigler, James W. Denham, Almudena Zapatero, Araceli Guerrero, David Joseph, Xavier Maldonado, Jessica K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar, Chandana Reddy, Trude B. Wedde, Wolfgang A. Lilleby, Ryan Fiano, Gregory S. Merrick, Richard G. Stock, D. Jeffrey Demanes, Brian J. Moran, Phuoc T. Tran, Santiago Martin, Rafael Martinez-Monge, Daniel J. Krauss, Eyad I. Abu-Isa, Thomas M. Pisansky, C. Richard Choo, Daniel Y. Song, Stephen Greco, Curtiland Deville, Todd McNutt, Theodore L. DeWeese, Ashley E. Ross, Jay P. Ciezki, Derya Tilki, R. Jeffrey Karnes, Jeffrey J. Tosoian, Nicholas G. Nickols, Prashant Bhat, David Shabsovich, Jesus E. Juarez, Tommy Jiang, T. Martin Ma, Michael Xiang, Rebecca Philipson, Albert Chang, Patrick A. Kupelian, Matthew B. Rettig, Felix Y. Feng, Alejandro Berlin, Jonathan D. Tward, Brian J. Davis, Robert E. Reiter, Michael L. Steinberg, David Elashoff, Paul C. Boutros, Eric M. Horwitz, Rahul D. Tendulkar, Daniel E. Spratt, Tahmineh Romero
Publikováno v:
JAMA oncology, vol 8, iss 3
JAMA Oncology
JAMA Oncology
Key Points Question What is the optimal minimum duration of androgen deprivation therapy (ADT) when treating high-risk prostate cancer with high-dose radiotherapy? Findings This patient-level cohort study of 3 cohorts found a significant interaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf4397cad9de2f66c9946476bffe693
https://escholarship.org/uc/item/9m28n0vg
https://escholarship.org/uc/item/9m28n0vg
Autor:
Jesus E. Juarez, Amar U. Kishan
Publikováno v:
Translational Cancer Research
Localised prostate cancer is commonly treated with external-beam radiotherapy. Moderate hypofractionation has been shown to be non-inferior to conventional fractionation. Ultra-hypofractionated stereotactic body radiotherapy would allow shorter treat
Autor:
Andrew Loblaw, Tahmineh Romero, Nicholas G. Nickols, Nima Aghdam, Sean P. Collins, Robert M. Meier, Patrick W. Linson, Amar U. Kishan, Jesus E. Juarez, Mark K. Buyyounouski, Simeng Suy, Constantine Mantz, Abigail Pepin, Huong T. Pham, Irving D. Kaplan, Alan J. Katz, Rebecca Levin-Epstein, R.L. Hong, Donald B. Fuller, Hilary P. Bagshaw, Michael L. Steinberg
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100759-(2021)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose: To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD). Methods and Materials: We queried a consortium database for patients with IBD receiving SBRT for prostate